These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 3971384
1. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM. Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384 [Abstract] [Full Text] [Related]
2. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV, Jin JK, Dougherty S, Flanigan RC, Graham S, Pyle JM. Cytometry; 1995 Sep 01; 21(1):30-9. PubMed ID: 8529468 [Abstract] [Full Text] [Related]
3. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy. Abaza R, Diaz LK, Laskin WB, Pins MR. J Urol; 2006 Dec 01; 176(6 Pt 1):2701-5. PubMed ID: 17085199 [Abstract] [Full Text] [Related]
4. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB. J Urol; 2002 Aug 01; 168(2):519-24. PubMed ID: 12131301 [Abstract] [Full Text] [Related]
5. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age. Shockley KF, Maatman TJ, Carothers GC, Warzynski MJ. Prostate; 1996 Jul 01; 29(1):46-50. PubMed ID: 8685055 [Abstract] [Full Text] [Related]
6. Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer. Lexander H, Palmberg C, Hellman U, Auer G, Hellström M, Franzén B, Jörnvall H, Egevad L. Proteomics; 2006 Aug 01; 6(15):4370-80. PubMed ID: 16888723 [Abstract] [Full Text] [Related]
7. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA. Urology; 1997 Sep 01; 50(3):379-84. PubMed ID: 9301701 [Abstract] [Full Text] [Related]
8. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB. Cancer Res; 1994 Jul 01; 54(13):3574-9. PubMed ID: 8012984 [Abstract] [Full Text] [Related]
9. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer. Häggarth L, Auer G, Busch C, Norberg M, Häggman M, Egevad L. Scand J Urol Nephrol; 2005 Jul 01; 39(5):387-92. PubMed ID: 16257840 [Abstract] [Full Text] [Related]
10. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Schröder F, Tribukait B, Böcking A, DeVere White R, Koss L, Lieber M, Stenkvist B, Zetterberg A. Scand J Urol Nephrol Suppl; 1994 Jul 01; 162():51-63; discussion 15-27. PubMed ID: 7529429 [Abstract] [Full Text] [Related]
11. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G. Cancer; 2007 Mar 01; 109(5):882-90. PubMed ID: 17262824 [Abstract] [Full Text] [Related]
12. DNA ploidy and survival in breast cancer patients. Cornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J. Cytometry; 1987 Mar 01; 8(2):225-34. PubMed ID: 3582068 [Abstract] [Full Text] [Related]
13. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Badalament RA, O'Toole RV, Young DC, Drago JR. Cancer; 1991 Jun 15; 67(12):3014-23. PubMed ID: 1710533 [Abstract] [Full Text] [Related]
14. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry. So MJ, Cheville JC, Katzmann JA, Riehle DL, Lohse CM, Pankratz VS, Sebo TJ. Mod Pathol; 2001 Sep 15; 14(9):906-12. PubMed ID: 11557788 [Abstract] [Full Text] [Related]
15. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma]. Zattoni F, Prayer Galetti T, Vianello F, Bertoldin R, Panozzo M, Blandamura S, Costantin G. J Urol (Paris); 1992 Sep 15; 98(4):192-5. PubMed ID: 1284300 [Abstract] [Full Text] [Related]
16. Tumor spread and DNA content in human renal cell carcinoma. Ljungberg B, Stenling R, Roos G. Cancer Res; 1988 Jun 01; 48(11):3165-7. PubMed ID: 3365699 [Abstract] [Full Text] [Related]
18. Prognostic value of DNA ploidy status in patients with rectal cancer. Berczi C, Bocsi J, Bartha I, Math J, Balazs G. Anticancer Res; 2002 Jun 01; 22(6B):3737-41. PubMed ID: 12552986 [Abstract] [Full Text] [Related]
19. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Nativ O, Umehara T, Colvard DS, Therneau TM, Farrow GM, Spelsberg TC, Lieber MM. Eur Urol; 1997 Jun 01; 32(1):96-9. PubMed ID: 9266239 [Abstract] [Full Text] [Related]
20. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer. Egawa S, Satoh T, Iwamura M, Aihara M, Kuwao S, Uchida T, Koshiba K. Urology; 1996 Apr 01; 47(4):548-52. PubMed ID: 8638366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]